Small Molecule, Multimodal, [F-18]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study
CLINICAL GENITOURINARY CANCER, cilt.19, sa.5, ss.405-416, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 19 Sayı: 5
- Basım Tarihi: 2021
- Doi Numarası: 10.1016/j.clgc.2021.03.011
- Dergi Adı: CLINICAL GENITOURINARY CANCER
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.405-416
- Anahtar Kelimeler: Image-guided surgery, Positron emission tomography, Prostate cancer, PSMA, PET imaging, RADICAL PROSTATECTOMY, PET
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
A number of radioactive tracers are currently being actively examined to image prostate-specific membrane antigen positive (PSMA+) tumors, especially in primary and recurrent prostate cancer. We report a first-in-human study of [18F]-BF3-Cy3-ACUPA by determining its safety, biodistribution, radiation dosimetry, and feasibility of tumor detection by preoperative positron emission tomography, as well as intraoperative fluorescence imaging, in patients with PSMA+ tumors.